Navigation Links
New advances in cancer research to be highlighted at University of Leicester
Date:4/21/2009

A scientist whose work is key to understanding how cancer cells divide and spread in the body is to present advances in his latest research at a public forum to be held at the University of Leicester.

Professor Andrew Fry, of the Department of Biochemistry, leads a renowned research group at the University of Leicester that is internationally consulted as a leading laboratory in the field of Molecular Cell Biology.

Many current cancer treatments act by killing all dividing cells and are not necessarily specific for the cancer cells, hence the severe side effects. One of Professor Fry's aims is to understand the molecular control of cell division and as a result identify proteins which can be targeted in specific tumours, leaving other cells unharmed.

On Tuesday April 28, Professor Fry will discuss his research and its future direction. The lecture, How Cells Control the Great Divide, in the Ken Edwards Building Lecture Theatre 1, starts at 5.30pm. It is open to the public and free.

Professor Fry said: "In my presentation, I will highlight how our research has contributed to the understanding of a key aspect of human cell biology that is cell division. This research has provided important new insights on the causes of many human diseases, including cancer, and led to the identification of a number of new targets for cancer treatment.

"An adult human being contains millions of cells that all arise following the fertilization of an egg cell by a sperm cell. Human development therefore requires cells to divide again and again to create the tissues and organs of our body. Cell division is a complex mechanical process that not only leads to the production of new cells but ensures that each one maintains the right genetic content required to sustain life. Loss of control over cell proliferation and the development of genetic and chromosomal abnormalities are classic hallmarks of cancer."

Professor Fry added that the group's research falls into three broad areas:

  • Study of a family of proteins that play a role in cell division and cilia organization which makes them attractive targets for the development of new anti-cancer drugs

  • Research on a particular structure that lies at the heart of each and every cell, called the centrosome (standing for "central body"), and how centrosome defects contribute to cancer progression

  • Examination of the cell biological basis of ciliopathy disorders, a diverse set of devastating human diseases with symptoms ranging from polycystic kidney disease to mental retardation, obesity and progressive blindness.

"Something that has helped us to establish a world-class reputation is a state-of-the-art Microscopy facility at the University of Leicester. The ability to use high resolution microscopy, to see what is actually going on in cells, is critical to research. So having this facility at Leicester allows us to compete at world level."


'/>"/>

Contact: Professor Andrew Fry
amf5@le.ac.uk
44-116-229-7069
University of Leicester
Source:Eurekalert

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
3. Major grant advances UWs clinical and translational research enterprise
4. Plastic Surgery 2007: Where Truth Behind Emerging Cosmetic Treatments Meets Amazing Reconstructive Advances
5. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
6. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
7. Advances in drug screening: building a better haystack for the needles of tomorrow
8. Advances in Cancer Research, Funding Stem Cell Research, and More at Annual Cancer Congress
9. UCLA, Tokyo University nanobiotechnology symposium at UCLA to highlight advances in nanomedicine
10. Springer adds Advances in Therapy to journals portfolio
11. NIH grant advances dentistry schools work on psychosocial stress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: